Abstract—
We present a novel computational ligand-based virtual screening approach with scaffold hopping capabilities for the identification of novel inhibitors of β-lactamases which confer bacterial resistance to β‑lactam antibiotics. The structures of known β-lactamase inhibitors were used as query ligands, and a virtual in silico screening a database of 8 million drug-like compounds was performed in order to select the ligands with similar shape and charge distribution. A set of numerical descriptors was used such as chirality, eigen spectrum of matrices of interatomic distances and connectivity together with higher order moment invariants that showed their efficiency in the field of pattern recognition but have not yet been employed in drug discovery. The developed scaffold-hopping approach was applied for the discovery of analogues of four allosteric inhibitors of serine β-lactamases. After a virtual in silico screening, the effect of two selected ligands on the activity of TEM type β-lactamase was studied experimentally. New non-β-lactam inhibitors were found that showed more effective inhibition of β-lactamases compared to query ligands.
Similar content being viewed by others
References
Schuffenhauer, A., WIREs Comput.Mol. Sci., 2012, vol. 2, pp. 842−867. https://doi.org/10.1002/wcms.1106
Schneider, G., Neidhart, W., Giller, T., and Schmid, G., Angew Chem. Int. Ed. Engl., 1999, vol. 38, pp. 2894−2896.
Sun, H., Tawa, G., and Wallqvist, A., Drug Discov. Today, 2012, vol. 17, pp. 310−324. https://doi.org/10.1016/j.drudis.2011.10.024
Brown, N. and Jacoby, E., Mini-Rev. Med. Chem., 2006, vol. 6, pp. 1217−1229. https://doi.org/10.2174/138955706778742768
Mauser, H. and Guba, W., Curr. Opin. Drug Discov. Devel., 2008, vol. 11, pp. 365−374.
Ballester, P.J. and Richards, W.G., J. Comput. Chem., 2007, vol. 28, pp. 1711−1723. https://doi.org/10.1002/jcc.20681
Wang, Q., Birod, K., Angioni, C., Grösch, S., Geppert , T., Schneider, P., Rupp, M., and Schneider, G., PLoS One, 2011, vol. 6, e21554. https://doi.org/10.1371/journal.pone.0021554
Willett, P., Methods Mol. Biol., 2011, vol. 672, pp. 133–158. https://doi.org/10.1007/978-1-60761-839-3_5
Rogers, D. and Hahn, M., J. Chem. Inf. Model, 2010, vol. 50, pp. 742–754. https://doi.org/10.1021/ci100050t
Hofmann, B., Franke, F., Proschak, E., Tanrikulu, Y., Schneider, P., Steinhilber, D., and Schneider, G., Chem. Med. Chem., 2008, vol. 3, pp. 1535–1538. https://doi.org/10.1002/cmdc.200800153
Daylight Chemical Information Systems. Available at: https://www.daylight.com (Accessed October 10, 2019).
Eckert, H. and Bajorath, J., Drug Discov. Today, 2007, vol. 12, pp. 225−233. https://doi.org/10.1016/j.drudis.2007.01.011
Grant, J.A., Gallardo, M.A., and Pickup, B.T., J. Comp. Chem., 1996, vol. 17, pp. 1653–1666. https://doi.org/10.1002/(SICI)1096-987X(19961115)17:14<1653::AID-JCC7>3.0.CO;2-K
Rush, T.S., Grant, J.A., Mosyak, L., and Nicholls, A., J. Med. Chem., 2005, vol. 48, pp. 1489–1495. https://doi.org/10.1021/jm040163o
OpenEye Scientific. Available at: http://www.eyesopen.com (Accessed October 10, 2019).
Yan, X., Li, J., Liu, Z., Zheng, M., Ge, H., and Xu, J., J. Chem. Inf. Model., 2013, vol. 53, pp. 1967−1978. https://doi.org/10.1021/ci300601q
Carosati, E., Sciabola, S., and Cruciani, G., J. Med. Chem., 2004, vol. 47, pp. 5114– 5125. https://doi.org/10.1021/jm0498349
Jenkins, J.L., Glick, M., and Davies, J.W., J. Med. Chem., 2004, vol. 47, pp. 6144–6159. https://doi.org/10.1021/jm049654z
Roy, A. and Skolnick, J., Bioinformatics, 2015, vol. 31, pp. 539-544. https://doi.org/10.1093/bioinformatics/btu692
Kirchmair, J., Wolber, G., Laggner, C., and Langer, T., J. Chem. Inf. Model., 2006, vol. 46, pp. 1848−1861. https://doi.org/10.1021/ci060084g
Sneader, W., Drug Prototypes and Their Exploitation, New York: Willey in Chichester, 1996.
Wavhale, R.D., Martis, E.A.F., Ambre, P.K., Wan, B., Franzblau, S.G., Iyer, K.R., Raikuvar, K., Macegoniuk, K., Berlicki, L., Nandan, S.R., and Coutin-ho, E.C., Bioorg. Med. Chem., 2017, vol. 25, pp. 4835−4844. https://doi.org/10.1016/j.bmc.2017.07.034
Naylor, N.R., Atun, R., Zhu, N., Kulasabanathan, K., Silva, S., Chatterjee, A., Knight, G.M., and Robotham, J.V., Antimicrob. Resist. Infect. Control, 2018, vol. 7, 58. https://doi.org/10.1186/s13756-018-0336-y
Fair, R.J. and Tor, Y., Perspect. Medicin. Chem., 2014, vol. 6, pp. 25−64. https://doi.org/10.4137/PMC.S14459
Eichenberger, E.M. and Thaden, J.T., Antibiotics, 2019, vol. 8, 37. https://doi.org/10.3390/antibiotics8020037
Munita, J.M. and Arias, C.A., Microbiol. Spectr., 2016, vol. 4, pp. 1−37. https://doi.org/10.1128/microbiolspec.VMBF-0016-2015
Bush, K., Antimicrob. Agents Chemother., 2018, vol. 62, pii: e01076-18. https://doi.org/10.1128/AAC.01076-18
Bush K. and Bradford, P.A., Nat. Rev. Microbiol., 2019, vol. 17, pp. 295−306. https://doi.org/10.1038/s41579-019-0159-8
King, D.T., Sobhanifar, S., and Strynadka, N.C.J., Protein Sci., 2016, vol. 25, pp. 787–803. https://doi.org/10.1002/pro.2889
Drawz, S.M. and Bonomo, R.A., Clin. Microbiol. Rev., 2010, vol. 23, pp. 160–201. https://doi.org/10.1128/CMR.00037-09
Wright, H., Bonomo, R.A., and Paterson, D.L., Clin. Microbiol. Infect., 2017, vol. 23, pp. 704–712. https://doi.org/10.1016/j.cmi.2017.09.001
Docquier, J.D. and Mangani, S., Drug Resist. Updat., 2018, vol. 36, pp. 13–29. https://doi.org/10.1016/j.drup.2017.11.002
Tuon, F.F., Rocha, J.L., and Formigoni-Pinto, M.R., Infection, 2018, vol. 46, pp. 165−181. https://doi.org/10.1007/s15010-017-1096-y
Blizzard, T.A., Chen, H., Kim, S., Wu, J., Bodner, R., Gude, C., Imbriglio, J., Young, K., Park, Y.W., Ogawa, A., Raghoobar, S., Hairston, N., Painter, R.E., Wisniewski, D., Scapin, G., Fitzgerald, P., Sharma N., Lu, J., Ha, S., Hermes, J., and Hammond, M.L., Bioorg. Med. Chem. Lett., 2014, vol. 24, pp. 780−785. https://doi.org/10.1016/j.bmcl.2013.12.101
Bush, K. and Page, M.G.P., J. Pharmacokinet. Pharmacodyn., 2017, vol. 44, pp. 113−132. https://doi.org/10.1007/s10928-017-9506-4
Wu, G. and Cheon, E., Expert Opin. Pharmacother., 2018, vol. 19, pp. 1495−1502. https://doi.org/10.1080/14656566.2018.1512586
Krajnc, A., Lang, P.A., Panduwawala, T.D., Brem, J., and Schofield, S.J., Curr. Opin. Chem. Biol., 2019, vol. 50, pp. 101–110. https://doi.org/10.1016/j.cbpa.2019.03.001
Giddins, M.J., Macesic, N., Annavajhala, M.K., Stump, S., Khan, S., McConville, T.H., Mehta, M., Gomez-Simmonds, A., and Uhlemann, A.C., Antimicrob. Agents Chemother., 2018, vol. 62, pii: e02101-17. https://doi.org/10.1128/AAC.02101-17
Both, A., Buttner, H., Huang, J., Perbandt, M., Belmar Campos, C., Christner, M., et al., J. Antimicrob. Chemother., 2017, vol. 72, pp. 2483−2488. https://doi.org/10.1093/jac/dkx179
Horn, J.R. and Schoichet, B.K., J. Mol. Biol., 2004, vol. 336, pp. 1283−1291. https://doi.org/10.1016/j.jmb.2003.12.068
Chen, Y. and Schoichet, B.K., Nat. Chem. Biol., 2009, vol. 5, pp. 358−364. https://doi.org/10.1038/nchembio.155
Langer, G.G., Evrard, G.X., Carolan, C.G., and Lamzin, V.S., J. Mol. Biol., 2012, vol. 419, pp. 211–222. https://doi.org/10.1016/j.jmb.2012.03.012
Hattne, J. and Lamzin, V.S., Acta Cryst. D, 2008, vol. 64, pp. 834−842. https://doi.org/10.1107/S0907444908014327
Hattne, J. and Lamzin, V.S., J. R. Soc. Interface, 2011, vol. 8, pp. 144−151. https://doi.org/10.1098/rsif.2010.0297
Heuser P., Langer G.G., Lamzin V.S., Acta Cryst. D, 2009, vol. 65, pp. 690−696. https://doi.org/10.1107/S090744490901991X
Carolan, C.G. and Lamzin, V.S., Acta Cryst. D, 2014, vol. 70, pp. 1844−1853. https://doi.org/10.1107/S1399004714008578
Tabachnick, B.G. and Fidell, L.S., in Using Multivariate Statistics, 3rd edn., New York: Harper Collins, 1996.
Burden, F.R., J. Chem. Inf. Comput. Sci., 1989, vol. 29, pp. 225–227.
Burden, F.R., Quant. Struct.-Act. Relat., 1997, vol. 16, pp. 309–314.
Marcus, M. and Smith, T.R., Linear Multilinear Algebra, 1989, vol. 25, pp. 219–230.
Sadjadi, F.A. and Hall, E.L., IEEE Trans. Pattern Anal. Mach. Intell., 1980, vol. 2, pp. 127−136.
Lo, C.H. and Don, H.S., IEEE Trans. Pattern Anal. Mach. Intell., 1989, vol. 11, pp. 1053−1064.
Grigorenko, V.G., Andreeva, I.P., Rubtsova, M.Y., Deygen, I.M., Antipin, R.L., Majouga, A.G., Egorov, A.M., Beshnova, D.A., Kallio, J., Hackenberg, C., and Lamzin, V.S., Biochimie, 2017, vol. 132, pp. 45−53. https://doi.org/10.1016/j.biochi.2016.10.011
Bebrone, C., Moali, C., Mahy, F., Rival, S., Docquier, J.D., Rossolini,G.M., Fastrez, J., Pratt, R.F., Frère, J.M., and Galleni, M., Antimicrob. Agents Chemother., 2001, vol. 45, pp. 1868−1871.
Antipin, R.L., Beshnova, D.A., Petrov, R.A., Shiryaeva, A.S., Andreeva, I.P., Grigorenko, V.G., Rubtsova, M.Yu., Majouga, A.G., Lamzin, V.S., and Egorov, A.M., BMC Lett., 2017, vol. 27, pp. 1588−1592. https://doi.org/10.1016/j.bmcl.2017.02.025
Stepto, R., Chang, T., Kratochvíl, P., Hess, M., Horie, K., Sato, T., and Vohlídal, J., Pure Appl. Chem., 2015, vol. 87, pp. 71−120.
Funding
The work on production of recombinant β-lactamase TEM-171 and inhibitory analysis has been supported by the Russian Science Foundation (project 15-14-00014-C). Virtual screening of the inhibitors was supported by the EMBL Interdisciplinary Postdocs (EIPOD) fellowship programme under Marie Skłodowska-Curie COFUND (grant no. 291 772) from the European Commission for the postdoctoral fellowship.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
COMPLIANCE WITH ETHICAL STANDARDS
This article does not contain any research involving humans or using animals as experimental objects.
CONFLICT OF INTEREST
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Beshnova, D.A., Carolan, C., Grigorenko, V.G. et al. Scaffold Hopping Computational Approach for Searching Novel β-Lactamase Inhibitors. Biochem. Moscow Suppl. Ser. B 14, 127–135 (2020). https://doi.org/10.1134/S199075082002002X
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S199075082002002X